ARCHIVES

FDA Advisors OK Levamisole, Conditional New Tamoxifen Use

This article is from The Cancer Letter archive.

Vol. 16 No. 06 | February 9, 1990

Download PDF Visit The Full Archive

Related Articles

NCI National Lab’s Budget to Grow Over Its $299.2 Million FY2013 Level

February 28, 2014

Also in this 8-page issue: The Cancer Letter wins two awards for its “authoritative examination” of NCI.

June 11, 2004

New Treatment Approaches for Leukemias Emerging From Early Clinical Trials

December 31, 2004

Pryor Calls For Price Regulation Of Drugs In Health Reform

February 12, 1993

Ten-Year Breast Cancer Survival Improved In Past 60 Years, MD Anderson Study Finds

October 29, 2010

Critics of FDA misunderstand Bayesian analysis, statisticians say.

August 5, 2005